• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮康唑诱导细胞色素P450eryF活性位点的构象变化。

Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.

作者信息

Cupp-Vickery J R, Garcia C, Hofacre A, McGee-Estrada K

机构信息

Department of Chemistry and Biochemistry, California State University, Fullerton, 800 N. State College Blvd., Fullerton, CA 92834, USA.

出版信息

J Mol Biol. 2001 Aug 3;311(1):101-10. doi: 10.1006/jmbi.2001.4803.

DOI:10.1006/jmbi.2001.4803
PMID:11469860
Abstract

The azole-based P450 inhibitor ketoconazole is used to treat fungal infections and functions by blocking ergosterol biosynthesis in yeast. Ketoconazole binds to mammalian P450 enzymes and this can result in drug-drug interactions and lead to liver damage. To identify protein-drug interactions that contribute to binding specificity and affinity, we determined the crystal structure of ketoconazole complexed with P450eryF. In the P450eryF/ketoconazole structure, the azole moiety and nearby rings of ketoconzole are positioned in the active site similar to the substrate, 6-deoxyerythronolide B, with the azole nitrogen atom coordinated to the heme iron atom. The remainder of the ketoconazole molecule extends into the active-site pocket, which is occupied by water in the substrate complex. Binding of ketoconazole led to unexpected conformational changes in the I-helix. The I-helix cleft near the active site has collapsed with a helical pitch of 5.4 A compared to 6.6 A in the substrate complex. P450eryF/ketoconazole crystals soaked in 6-deoxyerythronolide B to exchange ligands exhibit a structure identical with that of the original P450eryF/substrate complex, with the I-helix cleft restored to a pitch of 6.6 A. These findings indicate that the I-helix region of P450eryF is flexible and can adopt multiple conformations. An improved understanding of the flexibility of the active-site region of cytochrome P450 enzymes is important to gain insight into determinants of ligand binding/specificity as well as to evaluate models for catalytic mechanism based on static crystal structures.

摘要

基于唑类的细胞色素P450抑制剂酮康唑用于治疗真菌感染,其作用机制是阻断酵母中的麦角固醇生物合成。酮康唑与哺乳动物的细胞色素P450酶结合,这可能导致药物相互作用并引起肝损伤。为了确定有助于结合特异性和亲和力的蛋白质-药物相互作用,我们测定了酮康唑与P450eryF复合的晶体结构。在P450eryF/酮康唑结构中,酮康唑的唑基部分和附近的环位于活性位点,类似于底物6-脱氧红霉内酯B,唑氮原子与血红素铁原子配位。酮康唑分子的其余部分延伸到活性位点口袋中,该口袋在底物复合物中被水占据。酮康唑的结合导致I-螺旋发生意外的构象变化。活性位点附近的I-螺旋裂隙已经塌陷,螺旋间距为5.4 Å,而底物复合物中的螺旋间距为6.6 Å。浸泡在6-脱氧红霉内酯B中以交换配体的P450eryF/酮康唑晶体显示出与原始P450eryF/底物复合物相同的结构,I-螺旋裂隙恢复到6.6 Å的间距。这些发现表明P450eryF的I-螺旋区域是灵活的,可以采用多种构象。更好地理解细胞色素P450酶活性位点区域的灵活性对于深入了解配体结合/特异性的决定因素以及评估基于静态晶体结构的催化机制模型非常重要。

相似文献

1
Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.酮康唑诱导细胞色素P450eryF活性位点的构象变化。
J Mol Biol. 2001 Aug 3;311(1):101-10. doi: 10.1006/jmbi.2001.4803.
2
Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site.细胞色素P450eryF的结构:结合在活性位点的底物、抑制剂和模型化合物。
Steroids. 1997 Jan;62(1):112-6. doi: 10.1016/s0039-128x(96)00168-7.
3
7-Benzyloxyquinoline oxidation by P450eryF A245T: finding of a new fluorescent substrate probe.P450eryF A245T催化7-苄氧基喹啉氧化反应:新型荧光底物探针的发现
Chem Res Toxicol. 2002 Jun;15(6):806-14. doi: 10.1021/tx0200010.
4
A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.基于细胞色素P450 101、P450 102和P450 108晶体结构构建的人细胞色素P450 2D6三维蛋白质模型。
Chem Res Toxicol. 1996 Oct-Nov;9(7):1079-91. doi: 10.1021/tx960003i.
5
Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.填补细胞色素P450 BM3中的一个空洞可改善底物结合和催化效率。
J Mol Biol. 2007 Oct 26;373(3):633-51. doi: 10.1016/j.jmb.2007.08.015. Epub 2007 Aug 21.
6
A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.基于同源建模和底物结合的核磁共振研究建立的人细胞色素P450 2D6模型。
Biochemistry. 1996 Apr 9;35(14):4540-50. doi: 10.1021/bi952742o.
7
How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.底物如何进入以及产物如何离开细胞色素P450cam的埋藏活性位点?1. 配体进入通道和机制的随机排出分子动力学研究。
J Mol Biol. 2000 Nov 10;303(5):797-811. doi: 10.1006/jmbi.2000.4154.
8
Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF.野生型细胞色素P450eryF及其突变体A245S和A245T的亚铁双氧络合物的晶体结构:对P450eryF中质子转移系统的研究
J Biol Chem. 2005 Jun 10;280(23):22102-7. doi: 10.1074/jbc.M501732200. Epub 2005 Apr 11.
9
Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.咪唑基羧酸作为黄素细胞色素P-450 BM3的作用机制探针。
Biochemistry. 1998 Nov 10;37(45):15799-807. doi: 10.1021/bi980462d.
10
Azole drugs trap cytochrome P450 EryK in alternative conformational states.唑类药物将细胞色素 P450 EryK 困在替代构象状态中。
Biochemistry. 2010 Nov 2;49(43):9199-206. doi: 10.1021/bi101062v.

引用本文的文献

1
Structure-Function Analysis of the Essential P450 Drug Target, CYP121A1.结构功能分析必需的 P450 药物靶点 CYP121A1。
Int J Mol Sci. 2024 Apr 30;25(9):4886. doi: 10.3390/ijms25094886.
2
Structure-Function Analysis of the Biotechnologically Important Cytochrome P450 107 (CYP107) Enzyme Family.生物技术中重要的细胞色素 P450107(CYP107)酶家族的结构-功能分析。
Biomolecules. 2023 Dec 1;13(12):1733. doi: 10.3390/biom13121733.
3
Engineered EryF hydroxylase improving heterologous polyketide erythronolide B production in Escherichia coli.
工程化 EryF 羟化酶提高大肠杆菌中异源聚酮 erythronolide B 的产量。
Microb Biotechnol. 2022 May;15(5):1598-1609. doi: 10.1111/1751-7915.14000. Epub 2022 Feb 17.
4
Cytochrome P450 Enzymes and Their Roles in the Biosynthesis of Macrolide Therapeutic Agents.细胞色素P450酶及其在大环内酯类治疗药物生物合成中的作用。
Biomol Ther (Seoul). 2019 Mar 1;27(2):127-133. doi: 10.4062/biomolther.2018.183.
5
Might ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?结合生物标志物和自我报告数据能否改善抗逆转录病毒治疗依从性评估?
PLoS One. 2016 Dec 14;11(12):e0167852. doi: 10.1371/journal.pone.0167852. eCollection 2016.
6
Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.通过二维核磁共振和X射线晶体学分析细胞色素P450 CYP119配体依赖性构象动力学
J Biol Chem. 2015 Apr 17;290(16):10000-17. doi: 10.1074/jbc.M114.627935. Epub 2015 Feb 10.
7
Diversity of P450 enzymes in the biosynthesis of natural products.P450 酶在天然产物生物合成中的多样性。
Nat Prod Rep. 2012 Oct;29(10):1251-66. doi: 10.1039/c2np20020a. Epub 2012 Jul 23.
8
Systematic placement of structural water molecules for improved scoring of protein-ligand interactions.系统放置结构水分子以提高蛋白质-配体相互作用的评分。
Protein Eng Des Sel. 2011 Oct;24(10):777-89. doi: 10.1093/protein/gzr036. Epub 2011 Jul 19.
9
Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation.基于对接和分子动力学模拟探究质子泵抑制剂与人 P450 2C9 的结合。
J Mol Model. 2011 Aug;17(8):1941-51. doi: 10.1007/s00894-010-0903-5. Epub 2010 Dec 1.
10
Structural evidence for enhancement of sequential vitamin D3 hydroxylation activities by directed evolution of cytochrome P450 vitamin D3 hydroxylase.通过定向进化细胞色素 P450 维生素 D3 羟化酶增强维生素 D3 羟化酶顺序活性的结构证据。
J Biol Chem. 2010 Oct 8;285(41):31193-201. doi: 10.1074/jbc.M110.147009. Epub 2010 Jul 27.